Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-02

FDA Approved: ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical's acetaminophen 250 mg and ibuprofen 125 mg tablets through an original application (ANDA 219053).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG TABLETS (Acetaminophen 250 mg; Ibuprofen 125 mg)

Snippet

ORIG AP for ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG (ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG TABLETS)